Company · LT
Pioneera Biosciences
Biotech startup developing advanced CAR-T and CAR-NK therapies using AI.
- Raised
- EUR 5.0M
- Last round
- 18 Jun 2026
- Momentum
- Quiet
- Events
- 1
Updated 12 Sep 2026 · Reviewed 12 Sep 2026
Capital
1 round · 2026
18 Jun 2026
Funding round
€5.0M
Cumulative €5.0M
Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.
Activity
1 event
- Funding18 Jun 2026EUR 5.0M
Pioneera Biosciences raised over €5 million in its latest funding round.
▸Source: Startup Lithuania
“Advanced gene and cell therapy methods are opening new possibilities in medicine, and Lithuania is one of the countries where significant breakthroughs can be achieved. An increasingly strong and…”
People
1 person
Co-founder & CEO
Questions
4 answers
- What does Pioneera Biosciences do?
- Biotech startup developing advanced CAR-T and CAR-NK therapies using AI.
- Where is Pioneera Biosciences headquartered?
- Pioneera Biosciences is based in Lithuania.
- How much funding has Pioneera Biosciences raised?
- Pioneera Biosciences has raised €5.0M (across 1 round · last 18 Jun 2026).
- What was Pioneera Biosciences's latest funding round?
- Pioneera Biosciences's most recent disclosed round was a funding round of €5.0M, announced 18 June 2026.
The newsletter
One issue a week. Tuesday at 06:00 CET.
Funding rounds, exits, hires, and launches from eight Nordic and Baltic countries. Read in under five minutes, with one editor’s judgement on every issue.
No ads · No algorithmic feed · Free